The anti-GPC3 targeted therapies market is expected to witness growth in the coming years, driven by the increasing incidence of cancer cases, clinical pipeline activity, and anticipated regulatory ...

Big returns could be on the cards for buyers of this stock. The post Bell Potter says this growing ASX 200 stock can rise over 40% appeared first on The Motley Fool Australia.

Amazon Prime Day Sale starts tomorrow! Get massive discounts of up to 70% off on the best sunscreen brands. Team Health Shots ...

Julian McMahon’s official cause of death has been revealed days after the Nip/Tuck star's family confirmed his passing July 2 ...

The fluorescent labeling compound—dubbed "Sialyl Lewis Yellow"—was developed by an international team led from the Pohang University of Science and Technology in South Korea. It works by binding to ...

A new study led by investigators at the UCLA Health Jonsson Comprehensive Cancer Center may help explain why certain liver ...